May 21, 20244Norton Rose Fulbright enhances employment and labor practice with Washington, DC partner Gregory Ossi
June 21, 20234Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture
June 19, 20234The Italian Revenue Agency Qualifies Directors’ Reversible Remuneration For The Purposes Of Double Taxation Agrements.
May 21, 20244Norton Rose Fulbright enhances employment and labor practice with Washington, DC partner Gregory Ossi
Homepage Europe Europe Legal Chronicle Genmab A/S’s €20 Million Share Acquisition In CureVac AG Genmab A/S’s €20 Million Share Acquisition In CureVac AG January 22, 2020January 28, 2020 Paolo Bossi Simmons & Simmons has advised Danish biotechnology company Genmab A/S on its acquisition of shares in CureVac AG, to the amount of €20m. CureVac is a… This content is for Standard 1 Year members only.Login Join Now